Lataa...

When to Stop Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia

Strict criteria for when to stop tyrosine kinase inhibitor (TKI) therapy in clinical practice are not easily defined without an agreement on what probability of achieving a treatment-free remission (TFR) constitutes a medically acceptable standard and consideration of the potential medical risks of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Curr Treat Options Oncol
Päätekijä: Laneuville, Pierre
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2018
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842492/
https://ncbi.nlm.nih.gov/pubmed/29520446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-018-0532-2
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!